Company Filing History:
Years Active: 2001-2002
Title: Innovations by David B. Belanger in Dry Eye Treatment
Introduction
David B. Belanger is a notable inventor based in Fort Worth, TX, who has made significant contributions to the field of ophthalmology. With a total of five patents to his name, he has focused on developing innovative treatments for dry eye disorders. His work is particularly relevant in today's world, where dry eye conditions are increasingly common.
Latest Patents
Belanger's latest patents include groundbreaking advancements in the treatment of dry eye. One of his notable inventions is the "Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for treatment of dry eye." This patent discloses methods for utilizing Omega chain modified 15-HETE derivatives to effectively treat dry eye conditions. Another significant patent is for "15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders." This invention focuses on 15-HETE derivatives that offer enhanced metabolic stability, providing new avenues for treating dry eye disorders.
Career Highlights
David B. Belanger is currently associated with Alcon Universal Ltd., a leading company in eye care products. His role at Alcon has allowed him to leverage his expertise in developing innovative solutions for eye health. His contributions have not only advanced the company's product offerings but have also positively impacted the lives of individuals suffering from dry eye conditions.
Conclusion
David B. Belanger's work exemplifies the spirit of innovation in the medical field, particularly in ophthalmology. His patents reflect a commitment to improving treatment options for dry eye disorders, showcasing his dedication to enhancing patient care. Through his efforts, he continues to make a significant impact in the realm of eye health.